The Urinary Incontinence Treatment Study

Wake Forest University Health Sciences70 enrolled

Overview

Investigators plan a prospective cohort study with an adaptive design based on physical function status. The design will involve tracking the number of women recruited with physical function impairment and those without any functional impairment. Investigators aim to recruit similar numbers of women in each group. If they find unequal numbers, they will adapt recruit strategies based on a woman's functional status. Investigators will compare changes in outcome measures within and between groups after 6 and 12 weeks of pelvic floor muscle exercises (PFME). The change in pelvic floor strength/efficiency will be assessed by repeating the pelvic floor PERFECT assessment and will be compared between groups. Changes in UI symptoms, symptom severity, and impact of UI symptoms on quality of life will be determined using standardized measures described above. Data analysis will define associations between changes in PERFECT measures and the change in UI episodes (based on 3-day voiding diary), severity, and type (based on QUID-7), and impact on quality of life (PFIQ-7) within and between groups. Objective measurement of lower-extremity strength will inform the relationship between lower-extremity strength, pelvic floor strength, and UI symptoms at baseline and the 6-week visit.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Urinary Incontinence Sarcopenia

Interventions

Pelvic floor muscle exerciseBEHAVIORAL

Standardized pelvic floor muscle exercise regimen

Eligibility

Sex: FEMALEMin age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Women, age 70 years or older * Diagnosis of Urinary Incontinence (defined by the QUID assessment as having subscale score for stress ≥4, and/or urge score ≥ 6) * Willing and able to be compliant with pelvic floor muscle exercise intervention (standard of care) for 12 weeks and to log compliance * Willing and able to undergo an extensive physical function evaluation Exclusion Criteria: * Prior surgical intervention for urinary incontinence within the past 12 months * Hysterectomy within 12 months * Diagnosis of: * Pelvic Organ Prolapse beyond the hymenal ring * Urogenital Fistula * Neurogenic Overactive Bladder (associated with a diagnosis of Multiple -Sclerosis or Stroke within past 12 months) * Incomplete Bladder Emptying/Urinary Retention with PVR \>150 ml (measured by bladder scan) * Requires assisted device (4 point cane, walker) for ambulation all /most of the time or wheelchair bound * Having significant cognitive impairment or dementia * Unsafe to exercise (severe cardiopulmonary disease) * Unable/unwilling to provide informed consent * Determined otherwise ineligible by the principal investigator

Locations (1)

Wake Forest Baptist Health

Winston-Salem, North Carolina, United States

Outcomes

Primary Outcomes

Number of Urinary Incontinence Episodes

Using a three-day voiding diary

Time frame: Baseline

Number of Urinary Incontinence Episodes

Using a three-day voiding diary

Time frame: week 6

Number of Urinary Incontinence Episodes

Using a three-day voiding diary

Time frame: week 12

Secondary Outcomes

Power of Contractions

measurement of strength using perineometer

Time frame: week 12

Endurance

measure of how long they can hold contraction

Time frame: week 12

Repetition of Contractions

how many repetitions can they sustain

Time frame: week 12

Number of Fast Contractions

number of fast contractions that can be repeated

Time frame: week 12

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.